1. Home
  2. SDHC vs EVO Comparison

SDHC vs EVO Comparison

Compare SDHC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$14.12

Market Cap

121.9M

Sector

N/A

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.96

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDHC
EVO
Founded
2008
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.9M
778.3M
IPO Year
2023
2007

Fundamental Metrics

Financial Performance
Metric
SDHC
EVO
Price
$14.12
$1.96
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$14.60
$7.00
AVG Volume (30 Days)
30.9K
45.9K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$971,116,000.00
N/A
Revenue This Year
$4.21
$1.37
Revenue Next Year
$11.07
$10.05
P/E Ratio
$155.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.72
$1.90
52 Week High
$23.49
$4.27

Technical Indicators

Market Signals
Indicator
SDHC
EVO
Relative Strength Index (RSI) 45.76 36.82
Support Level $14.04 $1.90
Resistance Level $14.49 $3.84
Average True Range (ATR) 0.74 0.05
MACD -0.10 0.02
Stochastic Oscillator 37.16 8.20

Price Performance

Historical Comparison
SDHC
EVO

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: